Walgreens Boots Alliance (BUE:WBA) EBIT: ARS-5,531,665.43 Mil (TTM As of May. 2025)


What is Walgreens Boots Alliance EBIT?

Walgreens Boots Alliance BUE:WBA 15 EBIT is ARS-5,531,665.43 Mil as of May. 2025. GuruFocus rates BUE:WBA with a GF Score™ of 15/100. The stock has 7 warning signs investors should review.

Walgreens Boots Alliance's earnings before interest and taxes (EBIT) for the three months ended in May. 2025 was ARS60,364.30 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in May. 2025 was ARS-5,531,665.43 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Walgreens Boots Alliance's annualized ROC % for the quarter that ended in May. 2025 was 0.10%. Walgreens Boots Alliance's annualized ROC (Joel Greenblatt) % for the quarter that ended in May. 2025 was 0.77%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield.

Walgreens Boots Alliance  (BUE:WBA) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Walgreens Boots Alliance's annualized ROC % for the quarter that ended in May. 2025 is calculated as:

ROC % (Q: May. 2025 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Feb. 2025 ) + Invested Capital (Q: May. 2025 ))/ count )
=61547.916 * ( 1 - 0% )/( (61360840.717 + 66953479.954)/ 2 )
=61547.916/64157160.3355
=0.10 %

where

Invested Capital(Q: Feb. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=74567545.722 - 24196008.912 - ( 1202154.235 - max(0, 28232570.967 - 17243267.06+1202154.235))
=61360840.717

Invested Capital(Q: May. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=82149897.108 - 27336743.561 - ( 982399.427 - max(0, 30724246.162 - 18583919.755+982399.427))
=66953479.954

Note: The Operating Income data used here is four times the quarterly (May. 2025) data.

2. Joel Greenblatt's definition of Return on Capital:

Walgreens Boots Alliance's annualized ROC (Joel Greenblatt) % for the quarter that ended in May. 2025 is calculated as:

ROC (Joel Greenblatt) %(Q: May. 2025 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Feb. 2025  Q: May. 2025
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=241457.208/( ( (29969959.95 + max(-8155958.06, 0)) + (32857118.17 + max(-11037198.377, 0)) )/ 2 )
=241457.208/( ( 29969959.95 + 32857118.17 )/ 2 )
=241457.208/31413539.06
=0.77 %

where Working Capital is:

Working Capital(Q: Feb. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(6308123.812 + 8331183.722 + 1401805.291) - (24196008.912 + 0 + 1061.9730000012)
=-8155958.06

Working Capital(Q: May. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(6509875.718 + 8664052.774 + 1125616.692) - (27336743.561 + 0 + 0)
=-11037198.377

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (May. 2025) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Walgreens Boots Alliance's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: May. 2025 )
=-5531665.429/0.000
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Walgreens Boots Alliance EBIT Related Terms

Walgreens Boots Alliance EBIT Historical Data

* Premium members only.

The historical data trend for Walgreens Boots Alliance's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Walgreens Boots Alliance EBIT Chart

Walgreens Boots Alliance Annual Data
Trend Aug15 Aug16 Aug17 Aug18 Aug19 Aug20 Aug21 Aug22 Aug23 Aug24
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 76,576.29 209,698.99 578,337.65 -1,335,564.00 -12,802,883.68

Walgreens Boots Alliance Quarterly Data
Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 319,046.00 -808,043.98 -411,840.00 -4,372,145.75 60,364.30

BUE:WBA vs WGRX, PETS, BHIC: EBIT Comparison

For the Pharmaceutical Retailers subindustry, Walgreens Boots Alliance's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Walgreens Boots Alliance EV-to-EBIT vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Walgreens Boots Alliance's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Walgreens Boots Alliance's EV-to-EBIT falls into.


Walgreens Boots Alliance EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in May. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ARS-5,531,665.43 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of ARS-5,531,665.43 Mil mean?
Walgreens Boots Alliance (BUE:WBA) has a EBIT of ARS-5,531,665.43 Mil as of May. 2025. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Walgreens Boots Alliance.
Is Walgreens Boots Alliance's EBIT too high?
Walgreens Boots Alliance's current EBIT is ARS-5,531,665.43 Mil. Overall, Walgreens Boots Alliance has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does Walgreens Boots Alliance's EBIT compare to WGRX and PETS?
Walgreens Boots Alliance's EBIT of ARS-5,531,665.43 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Healthcare Providers & Services company?
A good EBIT depends on the Healthcare Providers & Services industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Walgreens Boots Alliance. Walgreens Boots Alliance's current EBIT is ARS-5,531,665.43 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Walgreens Boots Alliance stock overvalued right now?
Walgreens Boots Alliance (BUE:WBA) has a current EBIT of ARS-5,531,665.43 Mil. The current EBIT is ARS-5,531,665.43 Mil. Walgreens Boots Alliance's overall GF Score™ is 15/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Walgreens Boots Alliance (BUE:WBA), the current EBIT is ARS-5,531,665.43 Mil as of May. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Walgreens Boots Alliance Business Description

Address 108 Wilmot Road, Deerfield, IL, USA, 60015
Walgreens Boots Alliance is one of the largest retail pharmacy chains in the US, with over 8,000 locations. Nearly three quarters of Americans live within five miles of a Walgreens location. Roughly two thirds of revenue is generated from prescription drug sales; Walgreens makes up 20% of total prescription revenue in the US. Walgreens also generates sales from retail products (general wellness consumables and its own branded merchandise), European drug wholesale, and healthcare. With more locations incorporating additional services like Health Corner and Village Medical, Walgreens creates an omnichannel experience for patients and positions itself as a one-stop healthcare provider.